Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside revrse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection

A.I. Veldkamp, J.H. Beijnen, R.M.W. Hoetelmans

Research output: Contribution to journalArticleProfessional

Original languageUndefined/Unknown
Pages (from-to)55-61
Number of pages6
JournalJournal of chromatography. B, Biomedical sciences and applications
Volume734
Publication statusPublished - 1999

Cite this